Detroit News: Michigan Medicine, the University of Michigan health system, this week was denied doses of the antiviral medicine remdesivir after requesting it for COVID-19 patients.
In recent days, doctors and hospitals nationwide expressed frustration with the federal distribution of the country’s limited stock of remdesivir — the only drug approved to treat the illness COVID-19.
Officials have not publicly disclosed the criteria for determining which medical centers got doses of the drug, and physicians called the allocation uneven and confusing.
He communicated this week with a group of other infectious disease doctors and learned some hospitals had received doses that had no COVID cases, while major medical centers with COVID-positive patients in hard-hit areas were not on the approved list to receive the drug.
“We started to wonder, what is going on here? This isn’t making sense to us,” Kaul said.
Michigan Medicine has treated 440 COVID patients and as of Friday had 76 COVID inpatients, down from a high of 229 on April 15.
The state of Michigan has been among the hardest hit by the pandemic, with over 4,500 deaths — the fourth most of any U.S. state. read more…
ATTENTION READERS
We See The World From All Sides and Want YOU To Be Fully InformedIn fact, intentional disinformation is a disgraceful scourge in media today. So to assuage any possible errant incorrect information posted herein, we strongly encourage you to seek corroboration from other non-VT sources before forming an educated opinion.
About VT - Policies & Disclosures - Comment Policy
